VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2019 | LentiGlobin BB305 for β-Thalassemia

Christian Chabannon
EBMT 2019
Rare Diseases Thalassemia LentiGlobin BB305

In this video, Christian Chabannon, MD, PhD, of Institut Paoli-Calmettes, Marseille, France, speaks about LentiGlobin BB305 for β-Thalassemia. Prof. Chabannon was talking at the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany.

More from Christian Chabannon

5:42
EBMT survey & registry: CAR-T cell activities in Europe
Christian Chabannon • 1 Apr 2020
2:52
CAR T-cell therapy from a hospital perspective
Christian Chabannon
4:12
CAR-T supply chains in Europe
Christian Chabannon • 31 Mar 2020
3:15
Key updates in CAR-T therapy from EHA 2022
Christian Chabannon • 11 Jun 2022

Related Videos

3:23
Progression risk stratification of asymptomatic WM
Romanos Sklavenitis-Pistofidis
2:13
Founding precision therapy for 1q-amplified multiple myeloma
Romanos Sklavenitis-Pistofidis
1:49
CXCR4 in Waldenström’s macroglobulinemia
Zachary Hunter
6:57
Key updates in MPNs from ASH 2018
Claire Harrison
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals